Fortress Biotech (FBIO) Cash & Equivalents (2010 - 2026)
Fortress Biotech (FBIO) posted Cash & Equivalents of $196.58 million for Q2 2026, up 164.3% from $74.39 million a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Fortress Biotech's Cash & Equivalents came in at $79.38 million, up 38.6% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
- In prior years, Fortress Biotech's Cash & Equivalents was $57.26 million in FY2024 (-29.2%), $80.93 million in FY2023 (-54.6%), $178.27 million in FY2022 (-41.7%) and $305.74 million in FY2021 (+31.0%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q3 2022.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 29.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2026, with growth of 164.3%; the weakest was Q2 2023, with a decline of 68.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Fortress Biotech | 63.62 Mn | -512.45 Mn | 12.58 Mn | 196.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196.58 Mn |
| Mar 31, 2026 | 255.84 Mn |
| Dec 31, 2025 | 79.38 Mn |
| Sep 30, 2025 | 86.22 Mn |
| Jun 30, 2025 | 74.39 Mn |
| Mar 31, 2025 | 91.34 Mn |
| Dec 31, 2024 | 57.26 Mn |
| Sep 30, 2024 | 58.85 Mn |
| Jun 30, 2024 | 76.20 Mn |
| Mar 31, 2024 | 83.77 Mn |
| Dec 31, 2023 | 80.93 Mn |
| Sep 30, 2023 | 72.31 Mn |
| Jun 30, 2023 | 78.02 Mn |
| Mar 31, 2023 | 152.48 Mn |
| Dec 31, 2022 | 178.27 Mn |
| Sep 30, 2022 | 208.35 Mn |
| Jun 30, 2022 | 248.77 Mn |
| Mar 31, 2022 | 287.51 Mn |
| Dec 31, 2021 | 305.74 Mn |
| Sep 30, 2021 | 252.72 Mn |
API Access
Fortress Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();